D. Keating

1.8k citations

55 papers · 1.4k · 1 hit paper · h-index 17

Impact in

Pulmonary and Respiratory Medicine top 2%
- Cystic Fibrosis Research Advances
- Pulmonary Hypertension Research and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Orthopedics and Sports Medicine
- Bone health and osteoporosis research

Papers in

Pulmonary and Respiratory Medicine 38
- Cystic Fibrosis Research Advances 18
- Pulmonary Hypertension Research and Treatments 14
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Lung Cancer Diagnosis and Treatment 2
Surgery 7
- Transplantation: Methods and Outcomes 7

Co-authors: Tom C. Kotsimbos (19 shared papers)John W. Wilson (15 shared papers)Laura A. Sass (1 shared paper)Charlotte M. McKee (1 shared paper)Sarah M. C. Robertson (1 shared paper)Cori L. Daines (1 shared paper)Elizabeth D. Tullis (1 shared paper)Steven Mark Rowe (1 shared paper)
Journals: Journal of Cystic Fibrosis (7 papers)CHEST Journal (3 papers)Pediatric Pulmonology (2 papers)ERJ Open Research (2 papers)European Respiratory Journal (2 papers)
Partner nations: Australia Ireland New Zealand

In The Last Decade

D. Keating

51 papers receiving 1.4k citations

D. Keating's Hit Papers

align trajectories log scale

VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles 2018 · 582 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2018 New England Journal of Medicine

Peers

Countries citing papers authored by D. Keating

Since Specialization

Citations

This map shows the geographic impact of D. Keating's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Keating with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Keating more than expected).

Fields of papers citing papers by D. Keating

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Keating. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Keating. The network helps show where D. Keating may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Keating, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Keating Line = papers co-authored together D. Keating links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles New England Journal of Medicine ·D. Keating, Gautham Marigowda, Lucy D. Burr, Cori L. Daines, Marcus Alexander Mall, Edward F. McKone, Bonnie W. Ramsey, Steven Mark Rowe Hit paper breakdown →	2018	582
2	Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis BMC Musculoskeletal Disorders ·Conor J. Hurson, Joseph Simon Butler, D. Keating, David W. Murray, Denise M. Sadlier, John O’Byrne, Peter Doran	2007	78
3	Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry Respirology ·Victor Khou, James Anderson, Geoff A. Strange, Carolyn Corrigan, Nicholas John Collins, David Stephen Celermajer, Nathan Dwyer, John Feenstra	2020	67
4	Lung Transplantation in Pulmonary Fibrosis: Challenging Early Outcomes Counterbalanced by Surprisingly Good Outcomes Beyond 15 Years Transplantation Proceedings ·D. Keating, Bronwyn J. Levvey, Tom C. Kotsimbos, Helen M. Whitford, Glen Philip Westall, Gregory Snell +1 other	2009	56
5	Improvement in exercise duration, lung function and well-being in G551D-cystic fibrosis patients: a double-blind, placebo-controlled, randomized, cross-over study with ivacaftor treatment Clinical Science ·Deirdre M. Edgeworth, D. Keating, Brenda Button, E. Williams, Denise Clark, Audrey C. Tierney, Stephane R. Heritier, Tom C. Kotsimbos	2017	50
6	Microarray identifies ADAM family members as key responders to TGF-β1 in alveolar epithelial cells Respiratory Research ·D. Keating, Denise M. Sadlier, Andrea Patricelli, Sinéad M. Smith, Dermot Walls, Jim John Egan, Peter Doran	2006	46
7	Development of HPLC and LC–MS/MS methods for the analysis of ivacaftor, its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with ORKAMBI or KALYDECO Journal of Chromatography B ·Elena K. Schneider‐Futschik, Felisa Reyes‐Ortega, John W. Wilson, Tom C. Kotsimbos, D. Keating, Jian Li, Tony Velkov	2016	46
8	Body composition and weight changes after ivacaftor treatment in adults with cystic fibrosis carrying the G551 D cystic fibrosis transmembrane conductance regulator mutation: A double-blind, placebo-controlled, randomized, crossover study with open-label extension Nutrition ·Susannah J. King, Audrey C. Tierney, Deirdre M. Edgeworth, D. Keating, E. Williams, Tom C. Kotsimbos, Brenda Button, John W. Wilson	2021	40
9	Alveolar epithelial cell injury with Epstein-Barr virus upregulates TGFβ1 expression American Journal of Physiology-Lung Cellular and Molecular Physiology ·Andrea Patricelli Malizia, D. Keating, Sinéad M. Smith, Dermot Walls, Peter Doran, Jim John Egan	2008	38
10	Cadaveric Lobar Lung Transplantation: Technical Aspects The Annals of Thoracic Surgery ·Silvana Marasco, Stephanie Than, D. Keating, Glen Philip Westall, Helen M. Whitford, Greg I Snell, Julian H. Gooi, Trevor J. Williams	2012	38
11	Antibiotic exposure and interpersonal variance mask the effect of ivacaftor on respiratory microbiota composition Journal of Cystic Fibrosis ·Anton Yariv Peleg, Jocelyn M. Choo, Katherine M. Langan, Deirdre M. Edgeworth, D. Keating, John W. Wilson, Geraint B. Rogers, Tom C. Kotsimbos	2017	38
12	Advance Directives for Truth Disclosure CHEST Journal ·D. Keating, Kayser Nayeem, J J Gilmartin, Shaun T. O’Keeffe	2005	30
13	Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort CHEST Journal ·James Anderson, Edmund Lau, Melanie A. Lavender, Raymond L. Benza, David Stephen Celermajer, Nicholas John Collins, Carolyn Corrigan, Nathan Dwyer	2019	30
14	Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand Heart Lung and Circulation ·Geoff A. Strange, Edmund Lau, Eleni Giannoulatou, Carolyn Corrigan, Eugene Kotlyar, Fiona D. Kermeen, Trevor J. Williams, David Stephen Celermajer	2017	28
15	Long-term outcomes of cadaveric lobar lung transplantation: Helping to maximize resources The Journal of Heart and Lung Transplantation ·D. Keating, Silvana Marasco, Justin C. Negri, Donald S. Esmore, J H Burton, Mark Buckland, Glen Philip Westall, Trevor J. Williams	2010	27
16	VO2max as an exercise tolerance endpoint in people with cystic fibrosis: Lessons from a lumacaftor/ivacaftor trial Journal of Cystic Fibrosis ·John W. Wilson, Matt J. Ellis, Don S. Urquhart, Margaret E. Duncan, Simon Tian, Ryan Alan Harris, Tom C. Kotsimbos, D. Keating +2 others	2020	20
17	Pulmonary arterial hypertension with below threshold pulmonary vascular resistance European Respiratory Journal ·Seshika Ratwatte, James Anderson, Geoff A. Strange, Carolyn Corrigan, Nicholas John Collins, David Stephen Celermajer, Nathan Dwyer, John Feenstra	2020	17
18	Relationship between Trough Plasma and Epithelial Lining Fluid Concentrations of Voriconazole in Lung Transplant Recipients Antimicrobial Agents and Chemotherapy ·Siow Chin Heng, Gregory Snell, Bronwyn J. Levvey, D. Keating, Glen Philip Westall, Trevor J. Williams, Helen M. Whitford, Roger L. Nation	2013	16
19	Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis ERJ Open Research ·Susannah J. King, D. Keating, E. Williams, Eldho Mathew Paul, Brigitte M. Borg, F. Finlayson, Brenda Button, John W. Wilson	2020	15
20	Re-imagining cystic fibrosis care: next generation thinking European Respiratory Journal ·Catherine Rang, D. Keating, John W. Wilson, Tom C. Kotsimbos	2020	15

About D. Keating

D. Keating is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Internal Medicine, Complementary and alternative medicine and Infectious Diseases, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (18 papers), Pulmonary Hypertension Research and Treatments (14 papers), Transplantation: Methods and Outcomes (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Cardiovascular and exercise physiology (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (1k citations), Orthopedics and Sports Medicine (26 citations), Surgery (120 citations), Molecular Biology (137 citations) and Analytical Chemistry (23 citations). D. Keating has collaborated with scholars based in Australia, Ireland and New Zealand. Frequent co-authors include Tom C. Kotsimbos, John W. Wilson, Laura A. Sass, Charlotte M. McKee, Sarah M. C. Robertson, Cori L. Daines, Elizabeth D. Tullis, Steven Mark Rowe, Samuel M. Moskowitz and Fredrick Van Goor. Their work appears in journals such as Journal of Cystic Fibrosis, CHEST Journal, Pediatric Pulmonology, ERJ Open Research and European Respiratory Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

D. Keating

Impact in

Papers in i

In The Last Decade

D. Keating

D. Keating's Hit Papers

Peers

Countries citing papers authored by D. Keating

Fields of papers citing papers by D. Keating

All Works

About D. Keating

Explore authors with similar magnitude of impact

Papers in